Endoscopy 2016; 48(12): 1134-1142
DOI: 10.1055/s-0042-119395
Evidence in perspective
© Georg Thieme Verlag KG Stuttgart · New York

From POEM to POET: Applications and perspectives for submucosal tunnel endoscopy

Philip W. Y. Chiu
1   Department of Surgery, Institute of Digestive Disease, State Key Laboratory of Digestive Diseases, The Chinese University of Hong Kong, China
,
Haruhiro Inoue
2   Digestive Disease Center, Showa University Koto Toyosu Hospital, Japan
,
Thomas Rösch
3   Department of Interdisciplinary Endoscopy, University Hospital Hamburg-Eppendorf, Germany
› Author Affiliations
Further Information

Corresponding author

Philip W. Y. Chiu, MD
Department of Surgery, 4th floor Lui Che Woo Clinical Science Building
Prince of Wales Hospital
The Chinese University of Hong Kong
Fax: +852–2-6377974   

Publication History

Publication Date:
17 November 2016 (online)

 

Recent advances in submucosal endoscopy have unlocked a new horizon for potential development in diagnostic and therapeutic endoscopy. Increasing evidence has demonstrated that peroral endoscopic myotomy (POEM) is not only clinically feasible and safe, but also has excellent results in symptomatic relief of achalasia. The success of submucosal endoscopy in performance of tumor resection has confirmed the potential of this new area in diagnostic and therapeutic endoscopy. This article reviews the current applications and evidence, from POEM to peroral endoscopic tunnel resection (POET), while exploring the possible future clinical applications in this field.


#

Background and concept of submucosal endoscopy

Over the past decades, endoscopy has emerged from being a diagnostic tool into a therapeutic platform. Endoscopic resection for early gastrointestinal (GI) neoplasia began with the development of the first polypectomy snare in 1969 by Dr. Shinya [1], progressing subsequently to endoscopic mucosal resection (EMR) [2] using a variety of techniques [3], and finally to endoscopic submucosal dissection (ESD) to achieve en bloc resection for larger lesions. A new set of devices and enhanced electrosurgical units allowed endoscopists to perform ESD with secure hemostasis as well as closure of perforations [4]. Advances in endoluminal resection unleash the potential of advanced endoscopic surgical procedures, suturing, and device development [5] [6] [7] [8].

In addition, technical advances in endoscopy were inspired by the concept of natural orifice transluminal endoscopic surgery (NOTES), first proposed for transgastric peritoneoscopy in 2004 [9]. One of the important barriers to NOTES was the safety of the access to the peritoneal cavity and, even more so, the closure of that access [10]. In an animal model Sumiyama et al. explored the performance of a stepwise submucosal tunnel as a safe access to the peritoneal cavity [11] avoiding full-thickness incision and closure at a single site. Pasricha et al. took this idea further to carry out the first successful submucosal endoscopic myotomy in pigs [12]. Inoue et al. performed the world’s first clinical peroral endoscopic myotomy (POEM) for treatment of achalasia, and reported the first case series of 17 patients [13]: all patients had significant improvement in dysphagia score and lower esophageal sphincter pressure after POEM.

Following this initial description, there was an explosion of reports of small case series with short-term follow-up and encouraging clinical outcomes. In this early phase of a new technique, meta-analyses have already been conducted, even without randomized trials. The six systematic reviews and meta-analyses, which should rather be considered to be reviews, are shown in [Table 1] and [Table 2] [14] [15] [16] [17] [18] [19]. Three of them compared data between POEM and laparoscopic myotomy ([Table 2]) and, interestingly, two reviews on the same topic from two different groups of authors were published in two consecutive issues of the same journal [17] [18]. A seventh review deals with the few studies in children [20]. Despite similar search periods, the abovementioned reviews covered different papers/abstracts from different sources and generally reported a very high clinical efficacy with mostly short-term follow-up (6 – 8 months). The complication rates are highly variable since a uniform definition of complications, especially for minor complications, is still lacking. Another difficulty in interpretation of the clinical results is that some groups have reported results with increasing case numbers in several subsequent publications, so the overlap between the results is not always clear. A similar phenomenon can be observed for retrospective analyses and meta-analyses comparing POEM versus laparoscopic Heller myotomy (LHM) [18] [19] [21] [22] [23] [24] [25] [26]. The results of those studies suggested equivalent results for POEM and LHM, and are certainly interesting, but should mostly be considered as hypothesis-generating for better planning of randomized trials.

Table 1

Summary of reviews on early results of peroral endoscopic myotomy (POEM).

Authors

Search period

Studies, n

Cases, n

POEM operative time

Technical success

Clinical success

Complications

Follow-up period

GERD

Barbieri et al. [14]

2010 – 2013

16

551

156 mins
(range 42 – 112)

97 %

93 % as defined by clinically relevant improvement in dysphagia

Adverse events (14 %)

6 months

13 %

Talukdar et al. [15]

2005 – 2014

19

1045

NA

NA

Significant reduction in Eckardt score
Overall effect size (Z) of  – 7.95 (P < 0.0001)

1120 adverse events
Bleeding (n = 10)
Perforation (n = 27)
Subcutaneous emphysema (n = 228)
Mediastinal emphysema (n = 51)
Pneumoperitoneum (n = 169)
Pneumothorax (n = 91)
Pleural effusion (n = 182)
Pneumonia (n = 103)

6.5 months

10.9 %

Akintoye et al. [16]

Up to 2014

27

1733

88 ± 6 mins

NA

97 % as defined by Eckardt score < 3

Mucosal injury (9.4 %)
Esophageal perforation (0.3 %)
Bleeding (0.6 %)
Subcutaneous emphysema (11 %)
Pneumothorax (5.4 %)
Pneumoperitoneum (13 %)
Pleural effusion (9.5 %)

8.8 months

15 %

NA, not applicable; GERD, gastrointestinal reflux disease.

Table 2

Summary of systematic reviews and meta-analyses comparing peroral endoscopic myotomy (POEM) with laparoscopic Heller myotomy (LHM) for treatment of achalasia.

Authors

Search period

Studies, n

Patients, n

Operative time

Eckardt score

Length of hospital stay

Postoperative pain score

Complication

Marano et al. [17]

Up till 2015

7

LHM, 290
POEM, 196

No significant difference

No significant difference

Favors POEM

No significant difference

No significant difference

Total effect
(95 %CI):
– 0.354
(– 1.121 to 0.414)

Total effect
(95 %CI):
– 0.659
(– 1.704 to 0.387)

Total effect
(95 %CI):
– 6.290
(– 1.256 to – 0.002)

Total effect
(95 %CI):
– 1.869
(– 5.178 to 1.440)

Total effect
(95 %CI):
1.110
(0.505 – 2.440)

Zhang et al. [18]

1/1/2008 to 31/12/2014

4

LHM, 192
POEM, 125

No significant difference

No significant difference

No significant difference

NA

No significant difference

Total effect
(95 %CI)
– 55.62
(– 145.96 to 34.71)

Total effect
(95 %CI):
0.24
(– 0.61 to – 1.08)

Total effect
(95 %CI):
– 0.42
(– 1.26 to – 0.43)

OR
(95 %CI):
1.53
(0.65 to 3.59)

Patel et al. [19]

Up till 15/1/2014

3

LHM, 140
POEM, 73

No significant difference

NA

Nonsignificant trend favoring POEM

NA

No significant difference

Weighted mean difference
(95 %CI):
– 15.13 mins
(– 50.09 to 19.83)

Weighted mean difference
(95 %CI):
– 0.95 days
(– 1.92 to 0.01) (P = 0.05)

OR
(95 %CI):
1.2
(0.5 to 2.86)

OR, odds ratio; NA, not applicable; 95 %CI, 95 % confidence interval.


#

Clinical evidence for POEM: what is still lacking?

Mostly small cohort studies, on more than 4000 patients in total worldwide, confirmed the short-term clinical efficacy and relative safety of POEM for treatment of achalasia and other esophageal motility disorders. The incidence of severe adverse events during or after POEM remained uncommon, and POEM has been increasingly accepted as a noninvasive treatment for achalasia. Nevertheless, uniform definitions of minor or serious adverse events relating to POEM are urgently needed and should be used in further studies; for example, cutaneous emphysema and free abdominal air as sequelae or complications need to be defined.

The advantage of POEM is the achievement of myotomy similarly to that of a surgical approach but without incision; however long-term results are available from only very few studies. The clinical efficacy of POEM has remained excellent in studies from Asia [27] [28] [29], but a Western multicenter series suggested some loss of efficacy over time [30]. There is a need for more focus on reporting mid- to long-term results of 2 years and longer.

Gastroesophageal reflux disease (GERD) is another concern, currently overshadowed by optimistic assumptions that POEM might have reflux rates similar to those of laparoscopic myotomy. Again, reflux rates in East Asia are much lower than those reported from Western centers. In one of the reviews cited above, the overall rate of GERD and/or reflux esophagitis was 10.9 %, while studies from Western societies reported much higher rates of GERD ranging from 33 % to 72.2 % [15]. Most of the patients could obviously be managed by proton pump inhibitors (PPIs) in the short term. In another review, the rate of GERD was 8.5 %, and 13 % of patients had esophagitis while 47 % had abnormal acid exposure found in 24-hour pH studies [16]. Again, reports from Asia demonstrated a low rate of esophagitis while the rate apparently increased with increasing myotomy length and duration of the procedure. Another comparative study in 66 patients with achalasia demonstrated that POEM achieved similar GERD-related quality of life outcomes compared to LHM with fundoplication [21].

The next important issue concerns technical refinements of POEM for safe practice and long-term outcomes especially with respect to the development of GERD. Inoue et al. began performance of POEM using an anterior approach and a long myotomy at the 1-o’clock position [13]. The aim of using the anterior approach is to avoid damage to the angle of His and the sling muscle fibres located over the fundus at the greater curvature, which are important natural antireflux mechanisms. Zhou et al. reported the techniques of posterior myotomy, where the mucosal incision and the development of the submucosal tunnel is begun at the 5 – to 6-o’clock position [7]. The posterior approach allowed better alignment of the knife for performing myotomy, as the working channel for most endoscopes is located over the 5 – or 7-o’clock position. However, the angle of His is located at around the 8-o’clock position and posterior POEM may theoretically risk damage to the angle of His and disruption of the natural antireflux mechanism. Randomized trials comparing anterior versus posterior POEM will be necessary to assess their technical advantages and the incidence of GERD. Given that differences are expected to be minor, these studies will probably need large sample sizes.

Finally, the clinical efficacy of POEM versus its alternatives, mainly endoscopic pneumatic dilation and LHM should be compared in well-designed prospective randomized trials. The latter two therapies remain as well-established conventional treatments for achalasia [18] [31]. A search in clinicaltrial.gov using keywords “peroral endoscopic myotomy” or “achalasia” generated a list of 69 registered clinical trials. Eight of these study protocols focused on comparisons between POEM and other treatment modalities, including endoscopic botox injection, endoscopic pneumatic dilatation, and LHM; an overview is shown in [Table 3]. In addition, a multicenter prospective randomized trial comparing pneumatic dilation POEM was identified in the Netherlands trial registry (NTR3593); this is targeted to close by 2017.

Table 3

Clinical comparative trial protocols published in ClinicalTrials.gov on peroral endoscopic myotomy (POEM).

ClinicalTrials.gov identifier

Title

Type of study

Interventions

Inclusion

Primary outcome

Sample size

Country

Estimated completion date

NCT02663206

POEM vs. botulinum toxin injection in spastic esophageal disorders

RCT

1. POEM
2. Endoscopic botulinum toxin injection

Spastic disorders of the esophagus including
1. Spastic (type III) achalasia
2. Distal esophageal spasm
3. Hypercontractile (jackhammer) esophagus

Eckardt score

 50

United States

July 2020

NCT01768091

POEM vs. pneumatic dilation for esophageal achalasia

RCT

1. POEM
2. Endoscopic pneumatic dilation

Patients > 18 and < 75 years with achalasia

Symptom control to an Eckardt score of 3 or less

200

Guangzhou, China

December 2013

NCT02025790

POEM vs. pneumatic dilatation in achalasia cardia

Nonrandomized

1.POEM
2. Endoscopic pneumatic dilation

Patients > 18 and < 75 years with achalasia

Reduction in Eckardt score < 3 at 3 months

140

Hyderabad, India

December 2015

NCT01793922

Multicenter study comparing endoscopic pneumodilation and POEM

RCT

1. POEM
2. Endoscopic pneumatic dilation

Achalasia

Time to date of relapse of symptoms evaluated by Eckardt score

150

Belgium

January 2023

NCT02138643

Laparoscopic Heller myotomy (LHM) with fundoplication associated vs. POEM

RCT

1. POEM
2. LHM with fundoplication

Achalasia (dysphagia score > II and Eckardt > 3)

Remission of symptoms of dysphagia

 30

Sao Paulo, Brazil

February 2017

NCT02606578

POEM vs. laparoscopic modified Heller myotomy and antireflux procedures

Prospective Case – control

1. POEM
2. Laparoscopic modified Heller

Patients > 18 years old receiving POEM or LHM with antireflux procedure

Postoperative symptoms on the achalasia questionnaire at 2 years

100

Rochester, Minnesota, United States

October 2017

NCT0160678

Endoscopic versus laparoscopic myotomy for treatment of idiopathic achalasia: a randomized, controlled trial (POEM rcpmt)

RCT

1. POEM
2. LHM

Patients > 18 years with symptomatic achalasia

Noninferiority with treatment success defined as Eckardt score ≤ 3

240

Czech Republic; Germany; Italy; Netherlands; Sweden

December 2018

NCT02454335

POEM anterior vs. posterior approach

RCT

1. POEM anterior
2. POEM posterior

Patients > 18 years with confirmed achalasia on high resolution esophageal manometry

Change in Eckardt score up to 24 months

150

Baltimore, United States

January 2017

RCT, randomized controlled trial;


#

Submucosal tunneling beyond POEM

Submucosal transgastric endoscopic peritoneoscopy (STEP)

The submucosal tunneling technique was first conceptualized as a means of gaining safe access to the peritoneal cavity using flexible endoscopy [11]. Liu et al. reviewed publications on clinical applications of NOTES and found a total of 11 clinical studies reporting transgastric peritoneoscopy in 103 patients [32]. The indications included staging peritoneoscopy for carcinoma of pancreas or stomach and for those undergoing surgery for morbid obesity. After peritoneoscopy, most of the gastrotomies were either included in the surgical procedure or used for performance of gastrojejunostomy to avoid leakage. Lee et al. performed transgastric peritoneoscopy in five patients through submucosal tunneling [33]. All the submucosal transgastric endoscopic peritoneoscopies (STEPs) were technically successful with a mean hospital stay of 3.8 days.

It has to be said however, that, in contrast to POEM, this technique has not gained widespread acceptance. Furthermore, the indications for STEP are limited as advances in preoperative imaging allow accurate staging for intra-abdominal cancers.


#

Gastric peroral endoscopic pyloromyotomy (G-POEM)

Gastroparesis can cause debilitating symptoms of delayed gastric emptying including repeated nausea and vomiting [34]. Common causes of gastroparesis include diabetes mellitus, surgical or iatrogenic vagotomy, and an idiopathic pathogenesis. One of the hypothesized mechanisms for development of gastroparesis is the incoordination of peristalsis and relaxation of the pyloric antrum due to degeneration of myenteric plexus and loss of interstitial cells of Cajal [35]. The endoscopic injection of botulinum toxin was aimed at reducing the release of acetylcholine from cholinergic nerves and relaxing the pyloric sphincter [36]. Although prospective cohort studies demonstrated symptomatic improvements after endoscopic botox injection, two randomized controlled studies showed no improvement in symptoms and gastric emptying when endoscopic botox injection was compared with placebo [37] [38]. Laparoscopic pyloroplasty represented another approach to disrupting the pyloric constriction and relieving the obstruction, a concept similar to botox injection and pyloric stenting [39], but no evidence is available that compares this to other therapies.

Recently, the idea of POEM has been extended to performance of myotomy at the pylorus, with development of the gastric peroral endoscopic pyloromyotomy (G-POEM) [40] [41] [42]. Technically, the principles of G-POEM are similar to those of POEM, including creation of a submucosal tunnel, endoscopic myotomy, and closure of the mucosal entrance. The myotomy focused on inner circular and oblique muscle layers with sparing of the outer longitudinal layer, thus avoiding outer important structures including major vessels.

Early results from case reports and series demonstrated the technical success of G-POEM. Among the seven cases reported by Shlomovitz et al., one patient had difficulty in swallowing after peroral endoscopic pyloromyotomy and another patient had upper GI bleeding. Six of the seven patients had significant symptomatic improvement, while normal gastric emptying was observed in 80 % of cases [42]. Further clinical studies and long-term reports are necessary to confirm the efficacy and safety of G-POEM for treatment of gastroparesis.


#

Peroral endoscopic resection of submucosal tumors

Submucosal tunnel endoscopic resection (STER) or peroral endoscopic tunnel resection (POET) represents a novel approach to treatment of subepithelial tumors of the GI tract ([Fig. 1]). Subepithelial tumors of the GI tract comprise various pathologies arising from subepithelial tissues; the commonest types include gastrointestinal stromal tumors (GISTs), leiomyomas, schwannomas, lipomas, and ectopic pancreas. However, the real incidence of the various pathologies in esophagus, stomach, and duodenum is not fully known, especially for smaller lesions (< 2 or 3 cm), since surgical series include some referral bias towards more serious pathology and follow-up studies often lack tissue confirmation.

Zoom Image
Fig. 1 Submucosal tunnel endoscopic resection (STER)/peroral endoscopic tunneling resection (POET) for gastric subepithelial tumor. a Submucosal tumor located at the gastric cardia. b Dissection of the subepithelial tumor at cardia through a submucosal tunnel. c Closure of mucosal entrance with clips. d Resected 30-mm subepithelial tumor. e,f Schematic. The blue shading represents solution, containing indigo carmine, injected to raise the submucosa. e Development of the submucosal tunnel from esophagus to cardia. f Dissection of the subepithelial tumor at the cardia.

Many studies have covered endoscopic resection of subepithelial tumors of the upper GI tract using a variety of techniques; the issue of ESD for resection of subepithelial tumors [43] [44] [45] [46] [47] [48] will not be covered in detail here, since it represents a different principle and the risk of perforation amounted to 15 %. Technically, the risk of perforation during ESD will be determined by the extent of involvement in the muscular layer by the subepithelial tumor. By creation of a submucosal tunnel while maintaining the integrity of the overlying mucosa, endoscopic resection of submucosal tumors is possible without full-thickness perforation. Nine prospective studies have reported the performance of STER or POET for treatment of subepithelial tumors located in the esophagus or gastroesophageal junction, or, in some studies, also in the stomach [49] [50] [51] [52] [53] [54] [55] [56] [57] ([Table 4]). In most cases the pathology was leiomyoma or GIST of the upper gastrointestinal tract, and the most commonly reported complications included gas-related emphysema, pneumoperitoneum, and bleeding. The technique of STER/POET is still evolving, while the indications for applying such procedures for treatment of subepithelial tumors remain controversial [58] [59]. As there is a size limitation for tumors that can be removed perorally, tumors larger than 40 mm are generally not indicated for submucosal tunnel resection. Meanwhile, the risk of malignancy for submucosal tumors less than 20 mm in size is small and probably endoscopic/EUS surveillance should be recommended. Refinement in POET techniques and larger prospective cohort studies with longer-term follow-up should be conducted to confirm safety and oncological outcomes as well as the overall requirement for invasive treatment of these submucosal tumors.

Table 4

Selected clinical case series on submucosal tunnel endoscopic resection (STER) or peroral endoscopic tunnel resection (POET) for treatment of upper gastrointestinal subepithelial tumors.

Authors

Patients, n
Tumors, n

Location

Endoscopic technique

Size of subepithelial tumor, mean, mm

Operative time, mins

En bloc or complete resection

Complication(s)

Pathologies

Inoue et al. [49]

 9
 9

Esophagus
Cardia

POET

(Range 12 – 30)

Mean 152.4
(range 40 – 365)

7 /9

0 %

GIST, 1
Leiomyoma, 5
Aberrant pancreas, 1

Xu et al. [50]

15
15

Esophagus, 9
Cardia, 3
Stomach, 3

STER

19
(range 12 – 30)

Mean 78.7
(range 25 – 130)

NA

1 pneumothorax
1 emphysema
1 pneumoperitoneum

Gong et al. [51]

12
12

Esophagus, 8
Cardia, 4

Endoscopic submucosal tunneling

18.6

48.3

10 (83.3 %)

2 pneumothorax
2 emphysema

GIST, 7
Leiomyoma, 5

Liu et al. [52]

12
12

Esophagus, 7
Cardia, 5

STER

18.5 ± 6.9
(range 10 – 30)

78.3

NA

66.7 % emphysema
33.3 % pneumothorax
25.0 % pneumoperitoneum
16.7 % pleural effusion

Lu et al. [53]

18
19

Fundus

Transcardiac tunneling

20.1

75.1

19 (100 %)

2 pneumoperitoneum

GIST, 13
Leiomyoma, 6

Wang et al. [54]

57
57

Gastroesophageal junction, 57

STER

21.5

47

57 (100 %)

12 emphysema
5 pneumothorax
3 pneumoperitoneum
2 pleural effusion

GIST, 7
Leiomyoma, 46
Schwannoma, 2
Lipoma, 1
Granular cell tumor, 1

Zhou et al. [55]

21
21

Gastroesophageal junction

STER

23 (range 10 – 40)

62.9

NA

9 perforation

Leiomyoma, 15
GIST, 6

Wang et al. [56]

80
83

Esophagus, 67
Cardia, 16

STER

23.2

61.2

81 (97.6 %)

2 emphysema
1 pneumothorax
1 mucosal perforation

GIST, 15
Leiomyoma, 68

Li et al. [57]

32
32

Cardia, 15
Lesser curve, 6
Greater curve, 11

STER

23

51.8

32 (100 %)

1 bleeding
6 pneumoperitoneum
3 pneumothorax
3 emphysema

GIST, 11
Leiomyoma, 18
Fibrous tumor, 1
Glomus tumor, 1
Schwannoma, 1

GIST, gastrointestinal stromal tumor; NA, not applicable


#

Tunneling for endoscopic submucosal dissection (ESD)

The principle of tunneling has also been advocated for ESD especially of larger lesions in the esophagus [60] [61] [62] [63]. The technical advances in tunneling could be adopted, and make ESD resection easier, quicker, and perhaps safer. The impact of submucosal tunneling with regard to clinical outcomes and learning curve of ESD should be investigated in prospective randomized studies.


#
#

Submucosal endoscopy – what can we do in the future?

Based on prior NOTES experience, submucosal tunneling allowed endoscopists to access a completely new area of the GI tract beyond the mucosa. The tissues within reach of the submucosal tunnel include muscularis propria, submucosal (Meissner) nerve plexus, myenteric (Auerbach) nerve plexus, and other mesenchymal tissues. Diagnosis of submucosal diseases – if clinically indicated – can be greatly enhanced by endoscopic examination through the tunnel, as direct inspection of the disease pathology is possible ([Table 5]). Sumiyama et al. reported the observation of myenteric plexus using confocal endomicroscopy in colonic submucosa after ESD with application of acriflavine over the resected area [64], which is an interesting experimental approach. The direct examination of neurons and nerve plexus can be done through endomicroscopy for diagnosis of functional GI disorders especially when targeted probes are employed to enhance endoscopic molecular imaging [65] [66]. Sato et al. recently reported the diagnosis of eosinophilic esophageal myositis which caused the development of nutcracker and jackhammer esophagus [67]. Upon POEM, a biopsy of esophageal muscularis propria demonstrated eosinophilic infiltration. The observation of the eosinophilic infiltration was possible through the application of endomicroscopy in submucosal endoscopy. However, clinical utility has to be weighed against this approach which is rather aggressive compared to endoscopic biopsy and EUS-FNA.

Submucosal tunneling allows direct endoscopic examination of mediastinum and the peritoneal cavity, similarly to mediastinoscopy and diagnostic laparoscopy, as shown mostly in animals [68] [69]. However, appropriate clinical application will not be commensurate with the technological feasibility. The indications for mediastinoscopy are declining with advances in endobronchial ultrasound and transbronchial needle aspiration for nodal sampling [70]. Pulmonary biopsy would be another potential application through a transesophageal submucosal tunneling endoscopy [71]. Staging laparoscopy is regarded as one of the essential procedures for detection of peritoneal metastasis for carcinoma of stomach and pancreas, by some, but not all groups [72]. Kikuchi et al. reported that the diagnostic accuracy for peritoneal metastasis was significantly higher (83.8 % vs. 62.2 %) with laparoscopic narrow band imaging (NBI) compared with conventional laparoscopic white-light imaging [72], which implied that endoscopic NBI could achieve similar results without surgical incision.

Laparoscopic adjustable gastric banding for treatment of morbid obesity can sometimes lead to development of esophageal outflow obstruction mimicking achalasia, especially when band slippage occurs [73]. POEM has served as an alternative approach to relieve the high pressure at the lower esophageal sphincter without need for re-operation. Myotomy is one of the treatments for spastic disorders of the GI tract. Extension of this innovative submucosal approach can be considered beyond the upper GI tract. Bapaye et al. reported the first successful performance of per-rectal endoscopic myotomy (PREM) for treatment of a 24-year-old patient with Hirschsprung’s disease [74]. Future larger-scale clinical studies should evaluate this technique for treatment of Hirschsprung’s disease as well as for hypertensive anal sphincter and sphincter dyssynergia leading to chronic constipation and anal fissure [75] ([Table 5]). If myotomy can be performed for muscularis propria through submucosal endoscopy, treatment for damaged muscularis propria through submucosal endoscopy will be another future possibility. The extent to which submucosal endoscopy can be involved in antireflux treatment is yet to be defined. Submucosal injection of collagen at the lower esophageal sphincter has been described previously for treatment of GERD in 10 patients [76]. With regard to electrical stimulation of the lower esophageal sphincter [77], following miniaturization of the device and electrodes, endoscopic implantation may become possible through the submucosal tunneling approach.


#

Summary

Submucosal endoscopy represents a new horizon for innovative development in endoscopic diagnosis and treatment. This has led to a paradigm shift and offers a new working space for endoscopists to perform diagnostic and therapeutic procedures, for diseases within and outside the GI tract. However, the quality of clinical research is still limited, and we must await the results of ongoing randomized trials. Future research will focus on comparing the short- and long-term efficacy of POEM with that of other standard treatments for achalasia, on refining the techniques of POEM, and finally on extending the horizon of submucosal endoscopy to tumor resection and beyond.

Table 5

Current and future indications for submucosal endoscopy

Procedures

Diseases

Current indications

Functional disorders

Peroral endoscopic myotomy (POEM)

Achalasia
Diffuse esophageal spasm
Nutcracker esophagus

Gastric peroral endoscopic pyloromyotomy (G-POEM)

Gastroparesis
Delayed gastric emptying

Neoplasia

Peroral endoscopic tunnel resection (POET)/submucosal tunnel endoscopic resection (STER)

Esophageal subepithelial tumors
Gastric subepithelial tumors

Tunneling for endoscopic submucosal dissection (ESD) or pocket method for ESD

Early gastrointestinal neoplasia

Future potential applications

Diagnostic

Submucosal transgastric endoscopic peritoneoscopy

Peritoneal metastasis
Peritoneal infection (e. g. tuberculosis)

Functional disorders

Submucosal endoscopic diagnosis for functional disorders of upper gastrointestinal tract

Esophageal motility disorders

Per-rectal endoscopic myotomy

Hirschsprung disease

Submucosal endoscopic antireflux procedures (e. g. implants, augmentation materials, or electrical stimulation device)

Gastroesophageal reflux disease


#
#

Competing interests: None

  • References

  • 1 Wolff WI, Shinya H. Polypectomy via the fiberoptic colonoscope. Removal of neoplasms beyond reach of the sigmoidoscope. N Engl J Med 1973; 288: 329-332
  • 2 Inoue H, Fukami N, Yoshida T et al. Endoscopic mucosal resection for esophageal and gastric cancers. J Gastroenterol Hepatol 2002; 17: 382-388
  • 3 Soetikno RM, Gotoda T, Nakanishi Y et al. Endoscopic mucosal resection. Gastrointest Endosc 2003; 57: 567-579
  • 4 Maple JT, Abu Dayyeh BK, Chauhan SS. ASGE Technology Committee et al. Endoscopic submucosal dissection. Gastrointest Endosc 2015; 81: 1311-1325
  • 5 Chiu PW. Novel endoscopic therapeutics for early gastric cancer. Clin Gastroenterol Hepatol 2014; 12: 120-125
  • 6 Yamamoto K, Hayashi S, Saiki H et al. Endoscopic submucosal dissection for large superficial colorectal tumors using the “clip-flap method”. Endoscopy 2015; 47: 262-265
  • 7 Zhou PH, Schumacher B, Yao LQ et al. Conventional vs. waterjet-assisted endoscopic submucosal dissection in early gastric cancer: a randomized controlled trial. Endoscopy 2014; 46: 836-843
  • 8 Chiu PW, Phee SJ, Wang Z et al. Feasibility of full-thickness gastric resection using master and slave transluminal endoscopic robot and closure by Overstitch: a preclinical study. Surg Endosc 2014; 28: 319-324
  • 9 Kalloo AN, Singh VK, Jagannath SB et al. Flexible transgastric peritoneoscopy: a novel approach to diagnostic and therapeutic interventions in the peritoneal cavity. Gastrointest Endosc 2004; 60: 114-117
  • 10 ASGE; SAGES. ASGE/SAGES Working Group on natural orifice translumenal endoscopic surgery White Paper October 2005. Gastrointest Endosc 2006; 63: 199-203
  • 11 Sumiyama K, Gostout CJ, Rajan E et al. Transesophageal mediastinoscopy by submucosal endoscopy with mucosal flap safety valve technique. Gastrointest Endosc 2007; 65: 679-683
  • 12 Pasricha PJ, Hawari R, Ahmed I et al. Submucosal endoscopic esophageal myotomy: a novel experimental approach for the treatment of achalasia. Endoscopy 2007; 39: 761-764
  • 13 Inoue H, Minami H, Kobayashi Y et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy 2010; 42: 265-271
  • 14 Barbieri LA, Hassan C, Rosati R et al. Systematic review and meta-analysis: Efficacy and safety of POEM for achalasia. United European Gastroenterol J 2015; 3: 325-334
  • 15 Talukdar R, Inoue H, Reddy N. Efficacy of peroral endoscopic myotomy (POEM) in the treatment of achalasia: a systematic review and meta-analysis. Surg Endosc 2015; 29: 3030-3046 Epub 2014 Dec 25
  • 16 Akintoye E, Kumar N, Obaitan I et al. Peroral endoscopic myotomy: a meta-analysis. Endoscopy 2016; 48: 1059-1068
  • 17 Marano L, Pallabazzer G, Solito B et al. Surgery or peroral esophageal myotomy for achalasia: a systematic review and meta-analysis. Medicine (Baltimore) 2016; 95
  • 18 Zhang Y, Wang H, Chen X et al. Per-oral endoscopic myotomy versus laparoscopic heller myotomy for achalasia: a meta-analysis of nonrandomized comparative studies. Medicine (Baltimore) 2016; 95
  • 19 Patel K, Abbassi-Ghadi N, Markar S et al. Peroral endoscopic myotomy for the treatment of esophageal achalasia: systematic review and pooled analysis. Dis Esophagus 2016; 29: 807-819 Epub 2015 Jul 14
  • 20 Sharp NE, St Peter SD. Treatment of idiopathic achalasia in the pediatric population: a systematic review. Eur J Pediatr Surg 2016; 26: 143-149 Epub 2015 Feb 2
  • 21 Chan SM, Wu JC, Teoh AY et al. Comparison of early outcomes and quality of life after laparoscopic Heller’s cardiomyotomy to peroral endoscopic myotomy for treatment of achalasia. Dig Endosc 2016; 28: 27-32
  • 22 Kumbhari V, Tieu AH, Onimaru M et al. Peroral endoscopic myotomy (POEM) vs laparoscopic Heller myotomy (LHM) for the treatment of Type III achalasia in 75 patients: a multicenter comparative study. Endosc Int Open 2015; 3: E195-E201 Epub 2015 Apr 13
  • 23 Kumagai K, Tsai JA, Thorell A et al. Per-oral endoscopic myotomy for achalasia. Are results comparable to laparoscopic Heller myotomy?. Scand J Gastroenterol 2015; 50: 505-512 Epub 2015 Feb 24
  • 24 Bhayani NH, Kurian AA, Dunst CM et al. A comparative study on comprehensive, objective outcomes of laparoscopic Heller myotomy with per-oral endoscopic myotomy (POEM) for achalasia. Ann Surg 2014; 259: 1098-103
  • 25 Teitelbaum EN, Rajeswaran S, Zhang R et al. Peroral esophageal myotomy (POEM) and laparoscopic Heller myotomy produce a similar short-term anatomic and functional effect. Surgery 2013; 154: 885-891 ; discussion 891–892
  • 26 Hungness ES, Teitelbaum EN, Santos BF et al. Comparison of perioperative outcomes between peroral esophageal myotomy (POEM) and laparoscopic Heller myotomy. J Gastrointest Surg 2013; 17: 228-235 Epub 2012 Sep 28
  • 27 Lv L, Liu J, Tan Y et al. Peroral endoscopic full-thickness myotomy for the treatment of sigmoid-type achalasia: outcomes with a minimum follow-up of 12 months. Eur J Gastroenterol Hepatol 2016; 28: 30-36
  • 28 Hu JW, Li QL, Zhou PH et al. Peroral endoscopic myotomy for advanced achalasia with sigmoid-shaped esophagus: long-term outcomes from a prospective, single-center study. Surg Endosc 2015; 29: 2841-2850 Epub 2014 Dec 10
  • 29 Chen WF, Li QL, Zhou PH et al. Long-term outcomes of peroral endoscopic myotomy for achalasia in pediatric patients: a prospective, single-center study. Gastrointest Endosc 2015; 81: 91-100 Epub 2014 Aug 1
  • 30 Werner YB, Costamagna G, Swanström LL et al. Clinical response to peroral endoscopic myotomy in patients with idiopathic achalasia at a minimum follow-up of 2 years. Gut 2016; 65: 899-906
  • 31 Moonen A, Annese V, Belmans A et al. Long-term results of the European achalasia trial: a multicentre randomised controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy. Gut 2016; 65: 732-739
  • 32 Liu L, Chiu PW, Reddy N. APNOTES Working Group et al. Natural orifice transluminal endoscopic surgery (NOTES) for clinical management of intra-abdominal diseases. Dig Endosc 2013; 25: 565-577
  • 33 Lee SH, Kim SJ, Lee TH et al. Human applications of submucosal endoscopy under conscious sedation for pure natural orifice transluminal endoscopic surgery. Surg Endosc 2013; 27: 3016-3020
  • 34 Abrahamsson H. Treatment options for patients with severe gastroparesis. Gut 2007; 56: 877-883
  • 35 Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986; 90: 1919-1925
  • 36 Ukleja A, Tandon K, Shah K et al. Endoscopic botox injections in therapy of refractory gastroparesis. World J of Gastrointest Endosc 2015; 7: 790-798
  • 37 Arts J, Holvoet L, Caenepeel P et al. Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther 2007; 26: 1251-1258
  • 38 Friedenberg 1 FK, Palit A, Parkman HP et al. Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol 2008; 103: 416-423 Epub 2007 Dec 5
  • 39 Hibbard ML, Dunst CM, Swanström LL. Laparoscopic and endoscopic pyloroplasty for gastroparesis results in sustained symptom improvement. J Gastrointest Surg 2011; 15: 1513-1519
  • 40 Khashab MA, Stein E, Clarke JO et al. Gastric peroral endoscopic myotomy for refractory gastroparesis: first human endoscopic pyloromyotomy (with video). Gastrointest Endosc 2013; 78: 764-768
  • 41 Gonzalez JM, Vanbiervliet G, Vitton V et al. First European human gastric peroral endoscopic myotomy, for treatment of refractory gastroparesis. Endoscopy 2015; 47: E135-E136
  • 42 Shlomovitz E, Pescarus R, Cassera MA et al. Early human experience with per-oral endoscopic pyloromyotomy (POP). Surg Endosc 2015; 29: 543-551
  • 43 Ye LP, Zhu LH, Zhou XB et al. Endoscopic excavation for the treatment of small esophageal subepithelial tumors originating from the muscularis propria. Hepatogastroenterology 2015; 62: 65-68
  • 44 Chun SY, Kim KO, Park DS et al. Endoscopic submucosal dissection as a treatment for gastric subepithelial tumors that originate from the muscularis propria layer: a preliminary analysis of appropriate indications. Surg Endosc 2013; 27: 3271-3279
  • 45 Liu BR, Song JT, Qu B et al. Endoscopic muscularis dissection for upper gastrointestinal subepithelial tumors originating from the muscularis propria. Surg Endosc 2012; 26: 3141-3148
  • 46 He Z, Sun C, Wang J et al. Efficacy and safety of endoscopic submucosal dissection in treating gastric subepithelial tumors originating in the muscularis propria layer: a single-center study of 144 cases. Scand J Gastroenterol 2013; 48: 1466-1473
  • 47 Zhang Y, Ye LP, Zhou XB et al. Safety and efficacy of endoscopic excavation for gastric subepithelial tumors originating from the muscularis propria layer: results from a large study in China. J Clin Gastroenterol 2013; 47: 689-694
  • 48 Lee JS, Kim GH, Park DY et al. Endoscopic submucosal dissection for gastric subepithelial tumors: a single-center experience. Gastroenterol Res Pract 2015; 2015: 425-469
  • 49 Inoue H, Ikeda H, Hosoya T et al. Submucosal endoscopic tumor resection for subepithelial tumors in the esophagus and cardia. Endoscopy 2012; 44: 225-230
  • 50 Xu MD, Cai MY, Zhou PH et al. Submucosal tunneling endoscopic resection: a new technique for treating upper GI submucosal tumors originating from the muscularis propria layer (with videos). Gastrointest Endosc 2012; 75: 195-199
  • 51 Gong W, Xiong Y, Zhi F et al. Preliminary experience of endoscopic submucosal tunnel dissection for upper gastrointestinal submucosal tumors. Endoscopy 2012; 44: 231-235
  • 52 Liu BR, Song JT, Kong LJ et al. Tunneling endoscopic muscularis dissection for subepithelial tumors originating from the muscularis propria of the esophagus and gastric cardia. Surg Endosc 2013; 27: 4354-4359
  • 53 Lu J, Zheng M, Jiao T et al. Transcardiac tunneling technique for endoscopic submucosal dissection of gastric fundus tumors arising from the muscularis propria. Endoscopy 2014; 46: 888-892
  • 54 Wang XY, Xu MD, Yao LQ et al. Submucosal tunneling endoscopic resection for submucosal tumors of the esophagogastric junction originating from the muscularis propria layer: a feasibility study (with videos). Surg Endosc 2014; 28: 1971-1977
  • 55 Zhou DJ, Dai ZB, Wells MM et al. Submucosal tunneling and endoscopic resection of submucosal tumors at the esophagogastric junction. World J Gastroenterol 2015; 21: 578-583
  • 56 Wang H, Tan Y, Zhou Y et al. Submucosal tunneling endoscopic resection for upper gastrointestinal submucosal tumors originating from the muscularis propria layer. Eur J Gastroenterol Hepatol 2015; 27: 776-780
  • 57 Li QL, Chen WF, Zhang C et al. Clinical impact of submucosal tunneling endoscopic resection for the treatment of gastric submucosal tumors originating from the muscularis propria layer (with video). Surg Endosc 2015; 29: 3640-3646
  • 58 Eleftheriadis N, Inoue H, Ikeda H et al. Submucosal tunnel endoscopy: Peroral endoscopic myotomy and peroral endoscopic tumor resection. World J Gastrointest Endosc 2016; 8: 86-103
  • 59 Ng JJ, Chiu PW, Shabbir A et al. Removal of a large, 40-mm, submucosal leiomyoma using submucosal tunneling endoscopic resection and extraction of specimen using a distal mucosal incision. Endoscopy 2015; 47: E232-E233
  • 60 Imai K, Hotta K, Yamaguchi Y et al. Submucosal tunneling technique using insulated-tip knife in complete circumferential endoscopic submucosal dissection. Gastrointest Endosc 2016; 84: 742 Epub 2016 Apr 19
  • 61 Li B, Liu J, Lu Y et al. Submucosal tunneling endoscopic resection for tumors of the esophagogastric junction. Minim Invasive Ther Allied Technol 2016; 25: 141-147 Epub 2016 Apr 6
  • 62 Lu J, Zheng M, Jiao T et al. Transcardiac tunneling technique for endoscopic submucosal dissection of gastric fundus tumors arising from the muscularis propria. Endoscopy 2014; 46: 888-892 Epub 2014 Jul 18
  • 63 Linghu E, Feng X, Wang X et al. Endoscopic submucosal tunnel dissection for large esophageal neoplastic lesions. Endoscopy 2013; 45: 60-62 Epub 2012 Dec 19
  • 64 Sumiyama K, Kiesslich R, Ohya TR et al. In vivo imaging of enteric neuronal networks in human using confocal laser endomicroscopy. Gastroenterology 2012; 143: 1152-1153
  • 65 Coda S, Siersema PD, Stamp GW et al. Biophotonic endoscopy: a review of clinical research techniques for optical imaging and sensing of early gastrointestinal cancer. Endosc Int Open 2015; 3: E380-E392
  • 66 Chiu PWY, Chan FKL, Lau JYW et al. Probe based confocal endomicroscopy to determine the extent of myotomy during peroral endoscopic myotomy. J Gastroenterol Hepatol 2013; 28: 6-7
  • 67 Sato H, Takeuchi M, Takahashi K et al. Nutcracker and jackhammer esophagus treatment: a three-case survey, including two novel cases of eosinophilic infiltration into the muscularis propria. Endoscopy 2015; 47: 855-857
  • 68 Navarro-Ripoll R, Córdova H, Rodríguez-D’Jesús A et al. Cardiorespiratory impact of transesophageal endoscopic mediastinoscopy compared with cervical mediastinoscopy: a randomized experimental study. Surg Innov 2014; 21: 487-495
  • 69 Lerut T, De Leyn P, Coosemans W et al. Cervical videomediastinoscopy. Thorac Surg Clin 2010; 20: 195-206
  • 70 Medford AR, Bennett JA, Free CM et al. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA): applications in chest disease. Respirology 2010; 15: 71-79
  • 71 Fritscher-Ravens A, Patel K, Ghanbari A et al. Natural orifice transluminal endoscopic surgery (NOTES) in the mediastinum: long-term survival animal experiments in transesophageal access, including minor surgical procedures. Endoscopy 2007; 39: 870-875
  • 72 Kikuchi H, Kamiya K, Hiramatsu Y et al. Laparoscopic narrow-band imaging for the diagnosis of peritoneal metastasis in gastric cancer. Ann Surg Oncol 2014; 21: 3954-3962
  • 73 Pescarus R, Sharata A, Shlomovitz E et al. Endoscopic treatment for iatrogenic achalasia post-laparoscopic adjustable gastric banding. Surg Endosc 2016; 30: 3099 Epub 2015 Oct 30
  • 74 Bapaye A, Wagholikar G, Jog S et al. Per rectal endoscopic myotomy (PREM) for the treatment of adult Hirschsprung's disease: First human case (with video). Dig Endosc 2016; 28: 680-684 Epub 2016 Jul 29
  • 75 Farid M, El Nakeeb A, Youssef M et al. Idiopathic hypertensive anal canal: a place of internal sphincterotomy. J Gastrointest Surg 2009; 13: 1607-1613
  • 76 O’Connor KW, Lehman GA. Endoscopic placement of collagen at the lower esophageal sphincter to inhibit gastroesophageal reflux: a pilot study of 10 medically intractable patients. Gastrointest Endosc 1988; 34: 106-112
  • 77 Kappelle WF, Bredenoord AJ, Conchillo JM et al. Electrical stimulation therapy of the lower oesophageal sphincter for refractory gastro-oesophageal reflux disease – interim results of an international multicentre trial. Aliment Pharmacol Ther 2015; 42: 614-625

Corresponding author

Philip W. Y. Chiu, MD
Department of Surgery, 4th floor Lui Che Woo Clinical Science Building
Prince of Wales Hospital
The Chinese University of Hong Kong
Fax: +852–2-6377974   

  • References

  • 1 Wolff WI, Shinya H. Polypectomy via the fiberoptic colonoscope. Removal of neoplasms beyond reach of the sigmoidoscope. N Engl J Med 1973; 288: 329-332
  • 2 Inoue H, Fukami N, Yoshida T et al. Endoscopic mucosal resection for esophageal and gastric cancers. J Gastroenterol Hepatol 2002; 17: 382-388
  • 3 Soetikno RM, Gotoda T, Nakanishi Y et al. Endoscopic mucosal resection. Gastrointest Endosc 2003; 57: 567-579
  • 4 Maple JT, Abu Dayyeh BK, Chauhan SS. ASGE Technology Committee et al. Endoscopic submucosal dissection. Gastrointest Endosc 2015; 81: 1311-1325
  • 5 Chiu PW. Novel endoscopic therapeutics for early gastric cancer. Clin Gastroenterol Hepatol 2014; 12: 120-125
  • 6 Yamamoto K, Hayashi S, Saiki H et al. Endoscopic submucosal dissection for large superficial colorectal tumors using the “clip-flap method”. Endoscopy 2015; 47: 262-265
  • 7 Zhou PH, Schumacher B, Yao LQ et al. Conventional vs. waterjet-assisted endoscopic submucosal dissection in early gastric cancer: a randomized controlled trial. Endoscopy 2014; 46: 836-843
  • 8 Chiu PW, Phee SJ, Wang Z et al. Feasibility of full-thickness gastric resection using master and slave transluminal endoscopic robot and closure by Overstitch: a preclinical study. Surg Endosc 2014; 28: 319-324
  • 9 Kalloo AN, Singh VK, Jagannath SB et al. Flexible transgastric peritoneoscopy: a novel approach to diagnostic and therapeutic interventions in the peritoneal cavity. Gastrointest Endosc 2004; 60: 114-117
  • 10 ASGE; SAGES. ASGE/SAGES Working Group on natural orifice translumenal endoscopic surgery White Paper October 2005. Gastrointest Endosc 2006; 63: 199-203
  • 11 Sumiyama K, Gostout CJ, Rajan E et al. Transesophageal mediastinoscopy by submucosal endoscopy with mucosal flap safety valve technique. Gastrointest Endosc 2007; 65: 679-683
  • 12 Pasricha PJ, Hawari R, Ahmed I et al. Submucosal endoscopic esophageal myotomy: a novel experimental approach for the treatment of achalasia. Endoscopy 2007; 39: 761-764
  • 13 Inoue H, Minami H, Kobayashi Y et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy 2010; 42: 265-271
  • 14 Barbieri LA, Hassan C, Rosati R et al. Systematic review and meta-analysis: Efficacy and safety of POEM for achalasia. United European Gastroenterol J 2015; 3: 325-334
  • 15 Talukdar R, Inoue H, Reddy N. Efficacy of peroral endoscopic myotomy (POEM) in the treatment of achalasia: a systematic review and meta-analysis. Surg Endosc 2015; 29: 3030-3046 Epub 2014 Dec 25
  • 16 Akintoye E, Kumar N, Obaitan I et al. Peroral endoscopic myotomy: a meta-analysis. Endoscopy 2016; 48: 1059-1068
  • 17 Marano L, Pallabazzer G, Solito B et al. Surgery or peroral esophageal myotomy for achalasia: a systematic review and meta-analysis. Medicine (Baltimore) 2016; 95
  • 18 Zhang Y, Wang H, Chen X et al. Per-oral endoscopic myotomy versus laparoscopic heller myotomy for achalasia: a meta-analysis of nonrandomized comparative studies. Medicine (Baltimore) 2016; 95
  • 19 Patel K, Abbassi-Ghadi N, Markar S et al. Peroral endoscopic myotomy for the treatment of esophageal achalasia: systematic review and pooled analysis. Dis Esophagus 2016; 29: 807-819 Epub 2015 Jul 14
  • 20 Sharp NE, St Peter SD. Treatment of idiopathic achalasia in the pediatric population: a systematic review. Eur J Pediatr Surg 2016; 26: 143-149 Epub 2015 Feb 2
  • 21 Chan SM, Wu JC, Teoh AY et al. Comparison of early outcomes and quality of life after laparoscopic Heller’s cardiomyotomy to peroral endoscopic myotomy for treatment of achalasia. Dig Endosc 2016; 28: 27-32
  • 22 Kumbhari V, Tieu AH, Onimaru M et al. Peroral endoscopic myotomy (POEM) vs laparoscopic Heller myotomy (LHM) for the treatment of Type III achalasia in 75 patients: a multicenter comparative study. Endosc Int Open 2015; 3: E195-E201 Epub 2015 Apr 13
  • 23 Kumagai K, Tsai JA, Thorell A et al. Per-oral endoscopic myotomy for achalasia. Are results comparable to laparoscopic Heller myotomy?. Scand J Gastroenterol 2015; 50: 505-512 Epub 2015 Feb 24
  • 24 Bhayani NH, Kurian AA, Dunst CM et al. A comparative study on comprehensive, objective outcomes of laparoscopic Heller myotomy with per-oral endoscopic myotomy (POEM) for achalasia. Ann Surg 2014; 259: 1098-103
  • 25 Teitelbaum EN, Rajeswaran S, Zhang R et al. Peroral esophageal myotomy (POEM) and laparoscopic Heller myotomy produce a similar short-term anatomic and functional effect. Surgery 2013; 154: 885-891 ; discussion 891–892
  • 26 Hungness ES, Teitelbaum EN, Santos BF et al. Comparison of perioperative outcomes between peroral esophageal myotomy (POEM) and laparoscopic Heller myotomy. J Gastrointest Surg 2013; 17: 228-235 Epub 2012 Sep 28
  • 27 Lv L, Liu J, Tan Y et al. Peroral endoscopic full-thickness myotomy for the treatment of sigmoid-type achalasia: outcomes with a minimum follow-up of 12 months. Eur J Gastroenterol Hepatol 2016; 28: 30-36
  • 28 Hu JW, Li QL, Zhou PH et al. Peroral endoscopic myotomy for advanced achalasia with sigmoid-shaped esophagus: long-term outcomes from a prospective, single-center study. Surg Endosc 2015; 29: 2841-2850 Epub 2014 Dec 10
  • 29 Chen WF, Li QL, Zhou PH et al. Long-term outcomes of peroral endoscopic myotomy for achalasia in pediatric patients: a prospective, single-center study. Gastrointest Endosc 2015; 81: 91-100 Epub 2014 Aug 1
  • 30 Werner YB, Costamagna G, Swanström LL et al. Clinical response to peroral endoscopic myotomy in patients with idiopathic achalasia at a minimum follow-up of 2 years. Gut 2016; 65: 899-906
  • 31 Moonen A, Annese V, Belmans A et al. Long-term results of the European achalasia trial: a multicentre randomised controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy. Gut 2016; 65: 732-739
  • 32 Liu L, Chiu PW, Reddy N. APNOTES Working Group et al. Natural orifice transluminal endoscopic surgery (NOTES) for clinical management of intra-abdominal diseases. Dig Endosc 2013; 25: 565-577
  • 33 Lee SH, Kim SJ, Lee TH et al. Human applications of submucosal endoscopy under conscious sedation for pure natural orifice transluminal endoscopic surgery. Surg Endosc 2013; 27: 3016-3020
  • 34 Abrahamsson H. Treatment options for patients with severe gastroparesis. Gut 2007; 56: 877-883
  • 35 Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986; 90: 1919-1925
  • 36 Ukleja A, Tandon K, Shah K et al. Endoscopic botox injections in therapy of refractory gastroparesis. World J of Gastrointest Endosc 2015; 7: 790-798
  • 37 Arts J, Holvoet L, Caenepeel P et al. Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther 2007; 26: 1251-1258
  • 38 Friedenberg 1 FK, Palit A, Parkman HP et al. Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol 2008; 103: 416-423 Epub 2007 Dec 5
  • 39 Hibbard ML, Dunst CM, Swanström LL. Laparoscopic and endoscopic pyloroplasty for gastroparesis results in sustained symptom improvement. J Gastrointest Surg 2011; 15: 1513-1519
  • 40 Khashab MA, Stein E, Clarke JO et al. Gastric peroral endoscopic myotomy for refractory gastroparesis: first human endoscopic pyloromyotomy (with video). Gastrointest Endosc 2013; 78: 764-768
  • 41 Gonzalez JM, Vanbiervliet G, Vitton V et al. First European human gastric peroral endoscopic myotomy, for treatment of refractory gastroparesis. Endoscopy 2015; 47: E135-E136
  • 42 Shlomovitz E, Pescarus R, Cassera MA et al. Early human experience with per-oral endoscopic pyloromyotomy (POP). Surg Endosc 2015; 29: 543-551
  • 43 Ye LP, Zhu LH, Zhou XB et al. Endoscopic excavation for the treatment of small esophageal subepithelial tumors originating from the muscularis propria. Hepatogastroenterology 2015; 62: 65-68
  • 44 Chun SY, Kim KO, Park DS et al. Endoscopic submucosal dissection as a treatment for gastric subepithelial tumors that originate from the muscularis propria layer: a preliminary analysis of appropriate indications. Surg Endosc 2013; 27: 3271-3279
  • 45 Liu BR, Song JT, Qu B et al. Endoscopic muscularis dissection for upper gastrointestinal subepithelial tumors originating from the muscularis propria. Surg Endosc 2012; 26: 3141-3148
  • 46 He Z, Sun C, Wang J et al. Efficacy and safety of endoscopic submucosal dissection in treating gastric subepithelial tumors originating in the muscularis propria layer: a single-center study of 144 cases. Scand J Gastroenterol 2013; 48: 1466-1473
  • 47 Zhang Y, Ye LP, Zhou XB et al. Safety and efficacy of endoscopic excavation for gastric subepithelial tumors originating from the muscularis propria layer: results from a large study in China. J Clin Gastroenterol 2013; 47: 689-694
  • 48 Lee JS, Kim GH, Park DY et al. Endoscopic submucosal dissection for gastric subepithelial tumors: a single-center experience. Gastroenterol Res Pract 2015; 2015: 425-469
  • 49 Inoue H, Ikeda H, Hosoya T et al. Submucosal endoscopic tumor resection for subepithelial tumors in the esophagus and cardia. Endoscopy 2012; 44: 225-230
  • 50 Xu MD, Cai MY, Zhou PH et al. Submucosal tunneling endoscopic resection: a new technique for treating upper GI submucosal tumors originating from the muscularis propria layer (with videos). Gastrointest Endosc 2012; 75: 195-199
  • 51 Gong W, Xiong Y, Zhi F et al. Preliminary experience of endoscopic submucosal tunnel dissection for upper gastrointestinal submucosal tumors. Endoscopy 2012; 44: 231-235
  • 52 Liu BR, Song JT, Kong LJ et al. Tunneling endoscopic muscularis dissection for subepithelial tumors originating from the muscularis propria of the esophagus and gastric cardia. Surg Endosc 2013; 27: 4354-4359
  • 53 Lu J, Zheng M, Jiao T et al. Transcardiac tunneling technique for endoscopic submucosal dissection of gastric fundus tumors arising from the muscularis propria. Endoscopy 2014; 46: 888-892
  • 54 Wang XY, Xu MD, Yao LQ et al. Submucosal tunneling endoscopic resection for submucosal tumors of the esophagogastric junction originating from the muscularis propria layer: a feasibility study (with videos). Surg Endosc 2014; 28: 1971-1977
  • 55 Zhou DJ, Dai ZB, Wells MM et al. Submucosal tunneling and endoscopic resection of submucosal tumors at the esophagogastric junction. World J Gastroenterol 2015; 21: 578-583
  • 56 Wang H, Tan Y, Zhou Y et al. Submucosal tunneling endoscopic resection for upper gastrointestinal submucosal tumors originating from the muscularis propria layer. Eur J Gastroenterol Hepatol 2015; 27: 776-780
  • 57 Li QL, Chen WF, Zhang C et al. Clinical impact of submucosal tunneling endoscopic resection for the treatment of gastric submucosal tumors originating from the muscularis propria layer (with video). Surg Endosc 2015; 29: 3640-3646
  • 58 Eleftheriadis N, Inoue H, Ikeda H et al. Submucosal tunnel endoscopy: Peroral endoscopic myotomy and peroral endoscopic tumor resection. World J Gastrointest Endosc 2016; 8: 86-103
  • 59 Ng JJ, Chiu PW, Shabbir A et al. Removal of a large, 40-mm, submucosal leiomyoma using submucosal tunneling endoscopic resection and extraction of specimen using a distal mucosal incision. Endoscopy 2015; 47: E232-E233
  • 60 Imai K, Hotta K, Yamaguchi Y et al. Submucosal tunneling technique using insulated-tip knife in complete circumferential endoscopic submucosal dissection. Gastrointest Endosc 2016; 84: 742 Epub 2016 Apr 19
  • 61 Li B, Liu J, Lu Y et al. Submucosal tunneling endoscopic resection for tumors of the esophagogastric junction. Minim Invasive Ther Allied Technol 2016; 25: 141-147 Epub 2016 Apr 6
  • 62 Lu J, Zheng M, Jiao T et al. Transcardiac tunneling technique for endoscopic submucosal dissection of gastric fundus tumors arising from the muscularis propria. Endoscopy 2014; 46: 888-892 Epub 2014 Jul 18
  • 63 Linghu E, Feng X, Wang X et al. Endoscopic submucosal tunnel dissection for large esophageal neoplastic lesions. Endoscopy 2013; 45: 60-62 Epub 2012 Dec 19
  • 64 Sumiyama K, Kiesslich R, Ohya TR et al. In vivo imaging of enteric neuronal networks in human using confocal laser endomicroscopy. Gastroenterology 2012; 143: 1152-1153
  • 65 Coda S, Siersema PD, Stamp GW et al. Biophotonic endoscopy: a review of clinical research techniques for optical imaging and sensing of early gastrointestinal cancer. Endosc Int Open 2015; 3: E380-E392
  • 66 Chiu PWY, Chan FKL, Lau JYW et al. Probe based confocal endomicroscopy to determine the extent of myotomy during peroral endoscopic myotomy. J Gastroenterol Hepatol 2013; 28: 6-7
  • 67 Sato H, Takeuchi M, Takahashi K et al. Nutcracker and jackhammer esophagus treatment: a three-case survey, including two novel cases of eosinophilic infiltration into the muscularis propria. Endoscopy 2015; 47: 855-857
  • 68 Navarro-Ripoll R, Córdova H, Rodríguez-D’Jesús A et al. Cardiorespiratory impact of transesophageal endoscopic mediastinoscopy compared with cervical mediastinoscopy: a randomized experimental study. Surg Innov 2014; 21: 487-495
  • 69 Lerut T, De Leyn P, Coosemans W et al. Cervical videomediastinoscopy. Thorac Surg Clin 2010; 20: 195-206
  • 70 Medford AR, Bennett JA, Free CM et al. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA): applications in chest disease. Respirology 2010; 15: 71-79
  • 71 Fritscher-Ravens A, Patel K, Ghanbari A et al. Natural orifice transluminal endoscopic surgery (NOTES) in the mediastinum: long-term survival animal experiments in transesophageal access, including minor surgical procedures. Endoscopy 2007; 39: 870-875
  • 72 Kikuchi H, Kamiya K, Hiramatsu Y et al. Laparoscopic narrow-band imaging for the diagnosis of peritoneal metastasis in gastric cancer. Ann Surg Oncol 2014; 21: 3954-3962
  • 73 Pescarus R, Sharata A, Shlomovitz E et al. Endoscopic treatment for iatrogenic achalasia post-laparoscopic adjustable gastric banding. Surg Endosc 2016; 30: 3099 Epub 2015 Oct 30
  • 74 Bapaye A, Wagholikar G, Jog S et al. Per rectal endoscopic myotomy (PREM) for the treatment of adult Hirschsprung's disease: First human case (with video). Dig Endosc 2016; 28: 680-684 Epub 2016 Jul 29
  • 75 Farid M, El Nakeeb A, Youssef M et al. Idiopathic hypertensive anal canal: a place of internal sphincterotomy. J Gastrointest Surg 2009; 13: 1607-1613
  • 76 O’Connor KW, Lehman GA. Endoscopic placement of collagen at the lower esophageal sphincter to inhibit gastroesophageal reflux: a pilot study of 10 medically intractable patients. Gastrointest Endosc 1988; 34: 106-112
  • 77 Kappelle WF, Bredenoord AJ, Conchillo JM et al. Electrical stimulation therapy of the lower oesophageal sphincter for refractory gastro-oesophageal reflux disease – interim results of an international multicentre trial. Aliment Pharmacol Ther 2015; 42: 614-625

Zoom Image
Fig. 1 Submucosal tunnel endoscopic resection (STER)/peroral endoscopic tunneling resection (POET) for gastric subepithelial tumor. a Submucosal tumor located at the gastric cardia. b Dissection of the subepithelial tumor at cardia through a submucosal tunnel. c Closure of mucosal entrance with clips. d Resected 30-mm subepithelial tumor. e,f Schematic. The blue shading represents solution, containing indigo carmine, injected to raise the submucosa. e Development of the submucosal tunnel from esophagus to cardia. f Dissection of the subepithelial tumor at the cardia.